Literature DB >> 28711157

MAÏA Trapeziometacarpal Joint Arthroplasty: Clinical and Radiological Outcomes of 80 Patients With More than 6 Years of Follow-Up.

Adriano Toffoli1, Jacques Teissier2.   

Abstract

PURPOSE: Trapeziometacarpal (TMC) total joint replacement is increasingly being performed in Europe. MAÏA TMC total joint arthroplasty is a modular uncemented ball-and-socket hydroxyapatite-coated implant. This study assessed the midterm clinical and radiological results of the MAÏA TMC prosthesis.
METHODS: This single-center retrospective study involved 80 patients who underwent 96 MAÏA TMC prosthesis implantations from February 2006 to April 2009, and who had a minimum of 5 years' follow-up. Indications for the procedure were painful TMC joint osteoarthritis affecting activities of daily living and a failure of at least 6 months of nonsurgical treatment. Pre- and postoperative clinical and radiographic data were reviewed.
RESULTS: The mean age at surgery was 68 years (range, 53-84 years) and the median follow-up was 76 months (range, 60-102 months). The mean Quick Disabilities of the Arm, Shoulder, and Hand score improved from 61.3 ± 17.1 to 17.5 ± 16. The mobility of the thumb was restored to a range of motion comparable with that of the contralateral thumb. Opposition, defined by the Kapandji score, was almost normal (9.2 of 10; range, 6-10), as was the final mean key pinch and grip strength, which improved by 26% and 43%, respectively. Among the 96 implants, 4 (4.2%) were surgically revised for trapezium loosening. One dislocation was treated with closed reduction; 3 (3.1%) posttraumatic trapezium fractures were immobilized for 8 weeks. Among the 26 preoperative reducible z-deformities, only 5 (19.2%) were not totally corrected after surgery. The procedure success, by survival analysis over 6 years, was 93% (95% confidence interval, 87-98).
CONCLUSIONS: MAÏA TMC total joint arthroplasty may be a reliable treatment option for TMC joint osteoarthritis, with very good results for pain relief, strength, mobility, and restoration of the thumb length, providing correction of most thumb z-deformities. TYPE OF STUDY/LEVEL OF EVIDENCE: Therapeutic IV.
Copyright © 2017 American Society for Surgery of the Hand. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Trapeziometacarpal joint of the thumb; arthroplasty; osteoarthritis

Mesh:

Year:  2017        PMID: 28711157     DOI: 10.1016/j.jhsa.2017.06.008

Source DB:  PubMed          Journal:  J Hand Surg Am        ISSN: 0363-5023            Impact factor:   2.230


  5 in total

1.  Ivory Arthroplasty for Trapeziometacarpal Joint Arthritis in Men: Analysis of Clinical Outcome and Implant Survival.

Authors:  Bert Vanmierlo; John Buitenweg; Tim Vanmierlo; Kjell Van Royen; Francis Bonte; Jean Goubau
Journal:  Hand (N Y)       Date:  2020-07-22

2.  Elektra prosthesis versus resection-suspension arthroplasty for thumb carpometacarpal osteoarthritis: a long-term cohort study.

Authors:  Stefan M Froschauer; Matthias Holzbauer; Dietmar Hager; Richard Schnelzer; Oskar Kwasny; Dominik Duscher
Journal:  J Hand Surg Eur Vol       Date:  2019-09-11

3.  Tendon versus Pyrocarbon Interpositional Arthroplasty in the Treatment of Trapeziometacarpal Osteoarthritis.

Authors:  Won-Taek Oh; Yong-Min Chun; Il-Hyun Koh; Jong-Kwan Shin; Yun-Rak Choi; Ho-Jung Kang
Journal:  Biomed Res Int       Date:  2019-07-22       Impact factor: 3.411

Review 4.  Thumb CMCJ prosthetic total joint replacement: a systematic review.

Authors:  Thomas J Holme; Marta Karbowiak; Jennifer Clements; Ritesh Sharma; Johnathan Craik; Najab Ellahee
Journal:  EFORT Open Rev       Date:  2021-05-04

5.  Low rates of serious complications and further procedures following surgery for base of thumb osteoarthritis: analysis of a national cohort of 43 076 surgeries.

Authors:  Daniel Prieto-Alhambra; Dominic Furniss; Jennifer Ce Lane; Richard Craig; Jonathan L Rees; Matthew Gardiner; Mark M Mikhail; Nicholas Riley
Journal:  BMJ Open       Date:  2021-07-07       Impact factor: 2.692

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.